Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 06/07/2024, according to a recent filing. The shares, valued at an aggregate market value of $2,109.78, were originally acquired on 10/10/2022 as part of a restricted stock vesting agreement, which was compensation for Austin's role at Ginkgo Bioworks. This planned transaction follows a significant history of sales over the past three months, where a total of 253,952 shares were sold by Austin, generating total gross proceeds of $235,639.37. The notice of the upcoming sale was filed on the same date as the planned sale, with the original plan for the transaction adopted on 03/14/2023.

Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 06/07/2024, according to a recent filing. The shares, valued at an aggregate market value of $2,109.78, were originally acquired on 10/10/2022 as part of a restricted stock vesting agreement, which was compensation for Austin's role at Ginkgo Bioworks. This planned transaction follows a significant history of sales over the past three months, where a total of 253,952 shares were sold by Austin, generating total gross proceeds of $235,639.37. The notice of the upcoming sale was filed on the same date as the planned sale, with the original plan for the transaction adopted on 03/14/2023.